Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes

Journal of Invasive Cardiology

Volumn 21, Issue 9, 2009, Pages 446-450

  Park, Jai Wun ^a   Leitḧauser, Boris ^a   Gerk, Ulrich ^a   Vršansky, Martin ^b   Jung, Friedrich ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; NITINOL;

AGED; ARTICLE; BALLOON OCCLUSION; CLINICAL TRIAL; DEVICE REMOVAL; DEVICE THERAPY; FEMALE; FOLLOW UP; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS LEFT ATRIAL APPENDAGE TRANSCATHETER OCCLUSION; PERICARDIAL EFFUSION; PROSPECTIVE STUDY; RISK REDUCTION; STROKE; SURGICAL MORTALITY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ALLOYS; ANGIOPLASTY, BALLOON; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 71249124791     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Johnson WD, Ganjoo AK, Stone CD, et al. The left atrial appendage: Our most lethal human attachment! Surgical implications. Eur J Cardiothorac Surg 2000;17:718-722.
2. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. JAMA 2001;285:2370-2375.
3. Kannel WB, Benjamin EJ. Status of the epidemiology of atrial fibrillation. Med Clin North Am 2008;92:17-40, ix.
4. Aberg H. Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med Scand 1969;185:373-379.
5. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996;61:755-759.
6. Manning WJ, Weintraub RM, Waksmonski CA, et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med 1995;123:817-822.
7. Tsai LM, Chen JH, Lin LJ, Yang YJ. Role of transesophageal echocardiography in detecting left atrial thrombus and spontaneous echo contrast in patients with mitral valve disease or non-rheumatic atrial fibrillation. J Formos Med Assoc 1990;89:270-274.
8. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
9. Go AS, Hylek EM, Borowsky LH, et al. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med 1999;131:927-934.
10. Falk RH. Atrial fibrillation. N Engl J Med 2001;344:1067-1078.
11. Heuschmann PU, Kolominsky-Rabas PL, Kremer R, Neundörfer B. Pflege- und Versorgungsbedarf nach schlaganfall am beispiel des populationsbasierten erlanger schlaganfall projektes. Akt Neurologie 1998;25(Suppl 3):168.
12. Leung DY, Black IW, Cranney GB, et al. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol 1994;24:755-762.
13. Petersen P, Godtfredsen J. Risk factors for stroke in chronic atrial fibrillation. Eur Heart J 1988;9:291-294. (Pubitemid 18129241)
14. Stollberger C, Chnupa P, Kronik G, et al; for the ELAT Study Group. Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. Embolism in Left Atrial Thrombi study. Ann Intern Med 1998;128:630-638.
15. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999;131:492-501.
16. van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: An individual patient meta-analysis. JAMA 2002;288:2441-2448.
17. Oake N, Fergusson DA, Forster AJ, van Walraven C. Frequency of adverse events in patients with poor anticoagulation: A meta-analysis. CMAJ 2007;176:1589-1594.
18. Garcia-Fernandez MA, Perez-David E, Quiles J, et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: A transesophageal echocardiographic study. J Am Coll Cardiol 2003;42:1253-1258.
19. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-e231.
20. Blackshear JL, Johnson WD, Odell JA, et al. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J Am Coll Cardiol 2003;42:1249-1252.
21. Syed TM, Halperin JL. Left atrial appendage closure for stroke prevention in atrial fibrillation: State of the art and current challenges. Nat Clin Pract Cardiovasc Med 2007;4:428-435.
22. Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: Early clinical experience. Circulation 2002;105:1887-1889.
23. Sick PB, Turi ZG, Grube E, et al. Stroke prevention in non-valvular atrial fibrillation: Long-term results of the WATCHMAN left atrial appendage occlusion pilot study (Abstr). J Am Coll Cardiol 2009;53:A17.
24. Sick PB, Schuler G, Hauptmann KE, et al. Initial worldwide experience with the Watchman left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007;49:1490-1495.
25. Meier B, Palacios I, Windecker S, et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003;60:417-422.
26. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870.
27. Hart RG, Halperin JL, Pearce LA, et al. Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann Intern Med 2003;138:831-838.
28. Bungard TJ, Ghali WA, Teo KK, et al. Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med 2000;160:41-46.
29. Ostermayer SH, Reisman M, Kramer PH, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: Results from the international multi-center feasibility trials. J Am Coll Cardiol 2005;46:9-14.
30. Bayard YL, Ostermayer SH, Sievert H. Transcatheter occlusion of the left atrial appendage for stroke prevention. Expert Rev Cardiovasc Ther 2005;3:1003-1008.
31. Stollberger C, Schneider B, Finsterer J. Serious complications from dislocation of a Watchman left atrial appendage occluder. J Cardiovasc Electrophysiol 2007;18:880-881.
32. Stollberger C, Schneider B, Finsterer J. Elimination of the left atrial appendage to prevent stroke or embolism? Anatomic, physiologic, and pathophysiologic considerations. Chest 2003;124:2356-2362.
33. Stollberger C, Finsterer J, Schneider B. Does percutaneous closure of the left atrial appendage prevent stroke in atrial fibrillation? J Am Coll Cardiol 2006;47:1500-1501.
34. available at http://www.fda.gov/cdrh/panel/summary/circ-042309.html